A delayed clinical trial actually boosted Bristol Myers Squibb’s stock.
Here’s why.
-
Bristol Myers’ stock rallied Wednesday as investors maintained high hopes
for Cobenfy as an Alzheimer’s treatment, even though the outcome of a
late-stage ...
48 minutes ago
Posts
Seed Newsvine
.jpg)
At a Thursday speech in Michigan, Obama whined that “there was something wrong with our country,” because “Washington doesn’t have the capacity to come together and get things done.”
ReplyDeleteRead more: http://www.nypost.com/p/news/opinion/editorials/if_he_can_make_it_here_v3EvvbTBYl8rE0AU7i2NaI#ixzz1VAT2P0L7